Trials / Completed
CompletedNCT02597140
Pilot Study of Effect of Intravenous Lidocaine on Propofol Requirement in Facial Plastic Surgery
Pilot Study of Effect of Intravenous Lidocaine on Propofol Requirement During Monitored Anesthesia Care in Facial Plastic Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Academic / Other
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this randomized pilot study is to evaluate the effect of intravenous lidocaine on propofol requirement during BIS (Bispectral index) guided MAC (monitored anesthesia care) in facial plastic surgery.
Detailed description
Several studies reported the usefulness of intravenous lidocaine as a coadjuvant agent during general anesthesia. We thought that there would be an interaction between intravenous lidocaine and hypnotic agent requirement. However, there is no data regarding the effect of systemic lidocaine during MAC. We, thus, would like to perform a randomized, double-blinded pilot study to evaluate the effect of intravenous lidocaine on propofol requirement during BIS guided MAC in facial plastic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lidocaine | Patients in lidocaine group will be received an intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous infusion of 2 mg/kg/hr lidocaine. |
| DRUG | normal saline | Patients in control group will be received an intravenous bolus injection of 1.5 mg/kg normal saline followed by a continuous infusion of 2 mg/kg/hr normal saline. |
| DRUG | propofol | Propofol will be administered using target controlled infusion during monitored anesthesia care to adjust 60 to 80 of bispectral index. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-11-05
- Last updated
- 2019-07-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02597140. Inclusion in this directory is not an endorsement.